<\/p>\n
Draminate<\/strong> \u03b5\u03af\u03bd\u03b1\u03b9 dimenhydrinate 50 mg oral tablet<\/strong> used to prevent and treat \u03bd\u03b1\u03c5\u03c4\u03af\u03b1<\/strong>, vertigo<\/strong> (including Meniere’s disease and vestibular neuritis), and nausea and vomiting<\/strong> of vestibular origin. Dimenhydrinate is a first-generation H1 antihistamine<\/strong> with anticholinergic activity — the combination quiets the inner-ear vestibular signals that trigger motion sickness. Onset is 15\u201330 \u03bb\u03b5\u03c0\u03c4\u03ac<\/strong> after an oral dose; duration 4–6 hours<\/strong>. Take 30–60 minutes before travel<\/strong> for prevention; repeat every 4–6 hours, up to four doses per 24 hours. The commonest side effect is sedation<\/strong> — do not drive or operate machinery for at least 4 hours. Not “non-drowsy” despite marketing claims; second-generation antihistamines (cetirizine, loratadine) do not work for motion sickness — it needs the sedating H1 and the anticholinergic effect.<\/p>\n<\/div>\n Draminate is a dimenhydrinate 50 mg oral tablet<\/strong> used to prevent and treat motion sickness, vertigo, and nausea of vestibular origin. Dimenhydrinate itself is a chloro-theophyllinate salt of diphenhydramine (Benadryl); in the body it dissociates to release diphenhydramine, the active antihistamine, along with 8-chlorotheophylline (a mild stimulant that offsets some of the drowsiness). This is why dimenhydrinate is often described as “a little less sedating” than diphenhydramine alone — but it still causes significant drowsiness and should be treated as a sedating medication.<\/p>\n Dimenhydrinate is sold globally as Dramamine<\/strong> (US), Gravol<\/strong> (Canada), Vomex A<\/strong> (Germany), Travel Calm<\/strong> (various) and many generics. Draminate is the Indian generic brand; dosing and clinical indications are identical across brands. It is on the WHO List of Essential Medicines for vertigo.<\/p>\n The drug works best for vestibular-origin symptoms<\/strong>: motion sickness, inner-ear vertigo, labyrinthitis, Meniere’s attacks, and post-operative nausea after ear surgery. It is less effective<\/strong> for nausea of GI-origin (gastroenteritis, chemotherapy, migraine) — those usually respond better to ondansetron or metoclopramide.<\/p>\n Motion sickness happens when the vestibular system<\/strong> (inner-ear balance organs) and the visual system<\/strong> (eyes) send conflicting signals to the brain — for example, when you read in a moving car, your eyes say “still” but your inner ear says “accelerating round a bend”. The mismatch activates the vomiting centre<\/strong> in the medulla via histamine (H1) and muscarinic (M1) receptor pathways, producing nausea, pallor, cold sweat and vomiting.<\/p>\n Dimenhydrinate blocks both pathways:<\/p>\n Onset after a full oral dose is 15\u201330 \u03bb\u03b5\u03c0\u03c4\u03ac<\/strong>, peak blood levels at 1–2 hours<\/strong>, and clinical duration 4–6 hours<\/strong>. Elimination half-life is approximately 8 hours; sedation can linger longer.<\/p>\n Draminate is not a good choice<\/strong> for: chemotherapy-induced nausea (use 5-HT3 antagonists like ondansetron), gastroenteritis nausea, migraine-associated vomiting (metoclopramide + triptan), or nausea from opioids (use ondansetron or cyclizine).<\/p>\nWhat Is Draminate?<\/h2>\n
How Does Draminate Work?<\/h2>\n
\n
\u03a7\u03c1\u03ae\u03c3\u03b5\u03b9\u03c2 \u03ba\u03b1\u03b9 \u03b5\u03bd\u03b4\u03b5\u03af\u03be\u03b5\u03b9\u03c2<\/h2>\n
\n
Draminate Dosage<\/h2>\n